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Abstract 12 
Background: There are few prospective studies that relate the development of adult 13 
respiratory disease with exposure to occupational asthmagens. 14 
Objective: To evaluate the risk of adult onset wheeze (AOW) and obstructive lung function 15 
associated with occupational exposures over 50 years. 16 
Methods: A population-based randomly selected cohort of children who had not had asthma 17 
or wheezing illness, recruited in 1964 at age 10-15 years, was followed-up in 1989, 1995,  18 
2001 and 2014 by spirometry and respiratory questionnaire. Occupational histories were 19 
obtained in 2014 and occupational exposures determined with an asthma-specific job 20 
exposure matrix. The risk of AOW and lung function impairment was analysed in subjects 21 
without childhood wheeze using logistic regression and linear mixed effects models. 22 
Results: All 237 subjects (mean age 61 years, 47% male, 52% ever smoked) who took part in 23 
the 2014 follow-up had completed spirometry. Among those who did not have childhood 24 
wheeze, spirometry was measured in 93 subjects in 1989, in 312 in 1995 and in 270 subjects 25 
in 2001 follow-up. For longitudinal analysis of changes in FEV1 between 1989 and 2014 26 
spirometry records were available on 191 subjects at three time points and on 45 subjects at 27 
two time points, with a total number of 663 records. AOW and FEV1<LLN were associated 28 
with occupational exposure to food-related asthmagens (adjusted odds ratios (adjORs) 29 
95%CI: 2.7 [1.4, 5.1] and 2.9 [1.1, 7.7]) and biocides/fungicides (adjOR 95%CI: 1.8 [1.1, 3.1] 30 
and 3.4 [1.1, 10.8]), with evident dose-response effect (p-trends<0.05). Exposure to food-31 
related asthmagens was also associated with reduced FEV1, FVC and FEF25-75% (adjusted 32 
regression coefficients 95%CI:-7.2 [-12.0,-2.4], -6.2 [-10.9,-1.4], and -13.3 [-23.4,-3.3]). 33 
Exposure to wood dust was independently associated with AOW, obstructive lung function 34 
and reduced FEF25-75%. Excess FEV1 decline of 6-8ml/year was observed with occupational 35 
exposure to any asthmagen, biocides/fungicides and food-related asthmagens (p<0.05). 36 
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Conclusions: This longitudinal study confirmed previous findings of increased risks of adult 37 
onset wheezing illness with occupational exposure to specific asthmagens. A novel finding 38 
was the identification of food-related asthmagens and biocides/fungicides as potential new 39 
occupational risk factors for lung function impairment in adults without childhood wheeze.  40 
Key words: adult onset wheeze, ventilatory function, occupational exposure, asthmagens, 41 
cohort, job exposure matrix  42 
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1. INTRODUCTION 43 
Current evidence suggests that 17% of adult–onset asthma (ERS 2013) and up to 20% (50% 44 
among never smokers) of chronic obstructive pulmonary disease (COPD) (Sigsgaard et al. 45 
2010) can be attributed to work-related exposure. Although the prevalence of asthma in some 46 
westernised countries appears to be falling (Asher and Pearce 2014), the individual and 47 
societal burden of asthma remains high. Moreover the worldwide prevalence of asthma and 48 
COPD is rising (Anandan et al. 2010; GOLD 2014), and therefore the search for preventable 49 
environmental risk factors  remains important.  50 
 51 
Studies have shown certain occupational sensitisers to be associated with an increased risk of 52 
asthma, e.g. isocyanates, latex (Bakerly et al. 2008),  the role of irritant exposures in asthma 53 
aetiology is less well established (Brooks and Bernstein, 2011). Most evidence for the 54 
association between occupational exposure and respiratory symptoms, ventilatory function 55 
impairment and decline comes either from studies that examine specific exposures within 56 
single industries or occupational settings (Shi et al. 2010) or from general population cross-57 
sectional (Le Moual et al. 2004; Humerfelt et al. 1993) and case-control (Wang et al. 2010) 58 
studies. Such studies have inherent weaknesses, including healthy worker effect, self-59 
selection in job choice, case/control selection bias and the issue of generalisability, which 60 
may also preclude causal inference. Another weakness of epidemiological studies is their 61 
inability to accurately ascribe exposure measures. A few studies have prospectively examined 62 
associations with exposure to specific occupational substances in population-based cohorts, 63 
but with relatively short follow-up periods (Lillienberg et al. 2013; Humerfelt et al. 1993; 64 
Mehta et al. 2012).  65 
 66 
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The Aberdeen population-based WHEASE (What Happens Eventually to Asthmatic children: 67 
Sociologically and Epidemiologically) cohort study of children recruited in 1964 (Dawson et 68 
al. 1969) at age 10-15 years and followed up until 2014 (age 58-64 years) (Tagiyeva et al. 69 
2015) provides a rare opportunity to investigate the effects of lifetime occupational exposures 70 
on respiratory morbidity in later life.  71 
 72 
The aim of the current study was to investigate, in a community-based setting, whether 73 
occupational exposures to known asthmagens, assessed by job exposure matrix (JEM), were 74 
related to the development of adult onset wheeze (AOW), spirometry-defined airflow 75 
obstruction, or impaired ventilatory function at age 58-64 years and to longitudinal changes in 76 
ventilatory function over 25-year follow up among those who did not have wheezing illness 77 
as children.   78 
 79 
 80 
2. MATERIALS AND METHODS 81 
2.1. Subjects 82 
In 1964, the British Medical Research Council Medical Sociology Research Unit conducted a 83 
random community survey of all children attending primary school in the city of Aberdeen, 84 
Scotland in 1962 and still resident in Aberdeen at the time of selection. A 1-in-5 random 85 
sample was selected totalling 2,743 of whom 2,511 were interviewed at home with their 86 
parents. Amongst the 2,511 children aged 10-15 years interviewed, 288 were reported as 87 
having had wheeze and 2,223 as having no respiratory symptoms.  In a further study in 1964, 88 
those children who had wheezed were examined by a paediatrician, and 121 were classified 89 
as having asthma and 167 as having wheeze in the presence of upper respiratory tract 90 
infection (then termed wheezy bronchitis) (Dawson et al. 1969).  In 2014, a total of 583 91 
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individuals who took part in at least one previous follow up were traced and invited to take 92 
part. The current study reviews the outcome in 330 children who were traceable in 2014, of 93 
whom 239 did not have respiratory symptoms recorded in 1964. The analysis presented is for 94 
237 participants due to the availability of occupational exposure. 95 
 96 
Members of the cohort were reassessed in 1989 (aged 35-40, n=360), 1995 (aged 41-46, 97 
n=1542), 2001 (aged 47-52, n=381), and 2014 (aged 58-64, n=330) (Tagiyeva et al. 2015) 98 
(Table 1) to address differing  topical clinical questions using subsets of the original sample. 99 
The 1989, 1995 and 2001 follow-up phases included 93, 312 and 270 subjects with measured 100 
ventilatory function respectively, who had never wheezed as children (Godden et al. 1994; 101 
Bodner et al. 1998; Edwards et al. 2003). 102 
 103 
 104 
Table 1. The WHEASE cohort recruitment and follow up 105 
Original cohort 
1964 
The Medical Research Council random survey of Aberdeen schoolchildren 
Age 10-15 years 
2743 invited, 2511 participated: response rate 92% 
121 child asthma, 167 child wheezy bronchitis, 2223 child non-wheezers 
Spirometry measured in 288 child asthma & wheezy bronchitis 
 
What Happens Eventually to Asthmatic children: Sociologically and Epidemiologically 
(WHEASE) cohort 
1989 
WHEASE 1 to follow all child asthma and wheeze cases and selected non-wheezers  
Age 35-40 years 
455 traced and invited, 360 participated: response rate 79% 
Participants included:  
97 child asthma, 132 child wheezy bronchitis, 131 child non-wheezers 
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Spirometry measured in 272, including 93 child non-wheezers 
1995 
WHEASE 2 to follow all child non-wheezers  
Age 41-46 years 
1758 traced and invited to postal survey, 1542 participated in postal survey: response rate 88% 
Participants in postal survey: 
102 AOW, 1440 never-wheezers 
Clinical assessment (including spirometry) carried out in 312:  
102 AOW and 217 randomly selected never-wheezers 
2001 
WHEASE 3 to follow all in WHEASE 1 and those with spirometry in WHEASE 2  
Age 47-52 years 
605 traced and invited, 381 participated: response rate 63% 
Participants included: 46 child asthma, 65 child wheezy bronchitis, 270 child non-wheezers 
Spirometry measured in 372, including 270 child non-wheezers 
2014 
WHEASE 4 to follow all WHEASE 1, 2 & 3 with previously measured spirometry  
Age 58-64 years 
583 traced and invited, 330 participated: response rate 57% 
Participants included:  
38 child asthma, 53 child wheezy bronchitis, 239 child non-wheezers 
Spirometry measured in 329, including 239 child non-wheezers 
Occupational histories collected from 328, including 237 child non-wheezers  
  106 
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2.2.Assessments and outcomes 107 
Each follow up was carried out in the Chest Clinic, Aberdeen Royal Infirmary, and included 108 
the updated version of the MRC respiratory questionnaire (Medical Research Council 1986) 109 
administered during in-person interview (Supplemental Material, MRC questionnaire), and 110 
spirometry performed according to internationally accepted guidelines. The 2014 spirometry 111 
followed ATS/ERS guidelines (Pellegrino et al. 2005) with pre- and post-administration of 112 
400µg salbutamol using a Vitalograph Compact II spirometer (Vitalograph, Buckingham, 113 
UK). Forced expiratory volume in one second (FEV1), forced vital capacity (FVC) and forced 114 
expiratory flow over the middle half of FVC (FEF25–75) were recorded. Socio-demographic 115 
characteristics and history of cigarette smoking were also ascertained at interview. 116 
 117 
During the 2014 assessment a structured and detailed lifetime occupational history was 118 
recorded. This included descriptions of job title, main job services/tasks provided, industry, 119 
company, years job started and stopped, and type of employment (full- or part-time). 120 
 121 
2.3.Occupational data management 122 
Free-text descriptions of occupations and industries for all lifetime jobs were coded into four-123 
digit Standard Occupational Classification (SOC2000) codes developed by the UK Office for 124 
National Statistics (Office for National Statistics 2008) using the Computer Assisted 125 
Structured Coding Tool (CASCOT) (Jones and Elias 2014).  This generated certainty scores 126 
(1-100%) indicating the degree of certainty that the given code is correct. CASCOT derived 127 
occupational codes scores of >50% were accepted, and those scored ≤50% coded manually. 128 
This coding strategy has been shown to have 91% agreement with manually coded 129 
occupations (Tagiyeva et al. 2010).  130 
 131 
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In the current study, we used a JEM previously developed to evaluate exposure to 11 specific 132 
asthmagens (Tagiyeva et al, 2010), suitable for the UK workplace environment, based for 6 133 
of them (latex, wood, animal, enzyme, flour, isocyanate) on an update of exposure assessment 134 
from the JEM developed by Kennedy et al 2000. The presence and intensity of occupational 135 
exposure to 11 major occupational asthmagen groups: biocides/fungicides, glues/resins, latex, 136 
dyes, solder/flux, food-related asthmagens, wood dust, animal dust, enzyme products, 137 
flour/grains dust, and isocyanates, was assessed by two UK-based occupational hygienists 138 
based on the usual workplace environment in the UK during the 1990s while accounting for 139 
hazard controls that were commonly in place. This allowed for semi-quantitative evaluation 140 
(high, medium, low, zero) of intensity of exposure. This procedure is detailed in Tagiyeva et 141 
al (2010). Exposure to recognised occupational asthmagens was estimated by assigning an 142 
asthma-specific JEM to each 353 four-digit SOC2000 code. As occupational exposure data 143 
approximate to log-normal distribution, use of lognormal models for analysing workplace 144 
pollutant data is well established (Krishnamoorthy et al 2006). In the current study for each 145 
subject, the cumulative index of lifetime exposure was estimated by multiplying a logarithmic 146 
scale of exposure intensity by the number of years of exposure. Logarithmic values of 1, 3 147 
and 10 were used to represent the difference in assessed exposure categories of low, medium 148 
and high based on subjective assessment of the level of past exposure from airborne 149 
hazardous substances (Cherrie and Schneider 1999). 150 
 151 
 152 
 153 
 154 
 155 
 156 
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2.4.Statistical Analysis  157 
The primary outcomes were: adult onset wheeze (AOW), defined as wheeze ever reported at 158 
any follow up between 16-64 years of age, ventilatory function and airflow obstruction at age 159 
58-64 years and changes in ventilatory function during the 25-year follow-up period.  160 
 161 
Spirometric indices were expressed as percent predicted as defined by the ERS Global Lung 162 
Initiative, 2012 (Quanjer et al. 2012). Reduced FEV1 was defined as post-bronchodilator 163 
FEV1<lower 95% confidence limit of the internationally agreed predictive equations for 164 
normality (LLN) (Pellegrino et al. 2005; Quanjer et al. 2012). Airflow obstruction was 165 
defined as post-bronchodilator FEV1/FVC <0.7 (GOLD 2014). 166 
 167 
Exposures of interest were categorised as ever exposed versus never exposed and further 168 
categorised high, medium, low and zero exposure, latter to ascertain if degree/intensity of 169 
exposure had a different association with outcome. High, medium and low categories were 170 
generated using tertiles of cumulative indices of lifetime exposure. Exposures of interest in 171 
the longest and current/last held jobs were examined in separate models. 172 
 173 
Demographic characteristics were described using number and percentage if categorical 174 
variables or mean (standard deviation) if continuous (as normally distributed). Normality was 175 
assessed by skewness and kurtosis tests and histograms. Univariate comparisons of binary 176 
exposure (biocides/fungicides, glues/resins, latex, solder/flux, food-related asthmagens, wood 177 
dust, animal dust) with binary outcomes (AOW, FEV1 < LLN, FEV1/FVC < 0.7) were carried 178 
out using Chi-squared tests. For continuous outcomes (FEV1, FVC, FEF25%-75%) independent 179 
samples t-tests were used to assess differences in outcome between the exposure groups. 180 
Following this, logistic and linear regression analyses were implemented to adjust for 181 
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confounders (gender, smoking ever, highest education qualification). Different models were 182 
fitted: model A looked at the total count of exposures with outcome, model B a categorised 183 
count of exposures (0, 1-3, ≥4), model C the binary ‘any asthmagen’, and finally the D 184 
models looked at each exposure on its own with outcome. Any significant relationship in 185 
models D was further explored by categorising the exposure into none/low/med/high 186 
exposure.   187 
 188 
Linear mixed effect models with unstructured covariance were used to analyse changes in 189 
FEV1 between 1989 and 2014 in the exposed and non-exposed. Subjects with at least two 190 
spirometry test results were included in this analysis. Random effects were participant and 191 
participant*time with fixed effects of time and the confounding variables. Time was entered 192 
as a continuous variable into the model taking the values of 0, 6, 12, and 25 years to represent 193 
assessments made in 1989, 1995, 2001, and 2014.  Inclusion of an interaction term for time 194 
and exposure to individual substances allowed the production of estimates of change in FEV1 195 
between exposed and non-exposed. Analyses were performed using SPSS v22.0 (Armonk, 196 
NY, USA) and SAS v9.3 (SAS Institute Inc., Cary, USA). 197 
 198 
All analyses were adjusted for sex, history of having ever smoked more than 100 cigarettes, 199 
and the highest educational qualification obtained, used as an indicator of childhood and early 200 
adulthood socio-economic status. Linear mixed effect models were also adjusted for age (in 201 
1989). Interactions between exposure and smoking were analysed using separate logistic 202 
regression models for each asthmagen. Pack year data for smoking were not available, neither 203 
were the data to assess the temporal relationship between exposure and the onset of AOW. 204 
 205 
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Participants with unknown occupational history were excluded from the analysis. Jobs with 206 
less than one year duration were excluded from the estimation of exposure.  207 
 208 
 209 
3. RESULTS 210 
Of the 239 WHEASE participants assessed in 2014 with no history of childhood wheezing 211 
illness, occupational history was available for 237; of these 15% reported a diagnosis of 212 
asthma and 6% a diagnosis of COPD.  Approximately 8% of the cohort had FEV1<LLN and 213 
39% had FEV1/FVC<0.7. Characteristics of subjects who reported AOW and those who had 214 
never reported wheeze are detailed in Table 2. Those who had developed wheeze as adults 215 
were more likely to be overweight, have a history of smoking, be diagnosed with asthma and 216 
COPD, and have reduced ventilatory function. 217 
 218 
 219 
Table 2. Main demographic and health indicators of the study population in 2014  220 
Socio-demographic characteristics 
No childhood 
wheeze 
n 237 
AOWa 
n 95 
Never 
wheezed,  
n 142 
p for difference 
AOW vs never 
wheezedb 
Male sex, n (%) 111 (46.8) 46 (48.4) 65 (45.8) 0.689 
Age, years, mean±SD 60.6±1.5 60.8±1.5 60.5±1.5 0.149 
BMI, kg/m2, mean±SD 28.4±5.5 29.6±6.0 27.7±5.0 0.008 
Smoking ever, n (%) 124 (52.3) 61 (64.2) 63 (44.4) 0.003 
Smoking currently, n (%) 41 (17.3) 21 (22.1) 20 (14.1) 0.110 
Current exposure to ETSc, n (%) 42 (17.7) 25 (26.3) 17 (12.0) 0.005 
University degree and higher, n (%) 42 (17.7) 15 (15.8) 27 (19.0) 0.524 
Current work status, n (%)    
0.003 
Full-time 110 (46.4) 40 (42.1) 70 (49.3) 
Part-time 57 (24.1) 18 (18.9) 39 (27.5) 
Unemployed 6 (2.5) 3 (3.2) 3 (2.1) 
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Retired 44 (18.6) 18 (18.9) 26 (18.3) 
Not working due to ill health 20 (8.4) 16 (16.8) 4 (2.8) 
  Clinical, questionnaire-based, n (%)    
Diagnosed asthma ever 34 (14.7) 33 (37.1) 1 (0.7) <0.001 
Diagnosed COPD ever 15 (6.3) 15 (15.8) 0 (0.0) <0.001 
  Spirometry, postbronchodilator    
FEV1 % predicted, mean±SD 97.2±16.3 92.2±18.3 100.6±13.9 <0.001 
FVC % predicted, mean±SD 108.6±15.5 107.2±17.3 109.5±14.1 0.257 
FEF25-75% % predicted, mean±SD 77.8±33.6 68.0±33.0 84.4±32.5 <0.001 
FEV1<LLN, n (%) 20 (8.4) 15 (15.8) 5 (3.5) 0.001 
FEV1/FVC <0.7, n (%) 92 (38.8) 47 (49.5) 45 (31.7) 0.006 
FEV1 % predicted <80%, n (%) 30 (12.7) 21 (22.1) 9 (6.3) <0.001 
aAdult onset wheeze. bChi-squared test for categorical and t-test for continuous data analysis. 221 
cEnvironmental tobacco smoke. 222 
 223 
 224 
3.1.Exposure to occupational asthmagens 225 
All study participants had between one and six different jobs in their lifetime (median 2, IQR 226 
2-3). Most commonly reported occupations were storage and goods handling occupations, 227 
van drivers and maintenance managers among men and cleaning, general office workers, and 228 
sales assistants among women. Occupations in the WHEASE cohort categorised by exposure 229 
to at least one asthmagen and to 11 major occupational asthmagen groups by the intensity of 230 
exposure are presented in Table S1, Supplemental Material. While most occupations were not 231 
associated with any asthmagen exposures, others were characterised by multiple exposures 232 
patterns.   233 
 234 
The lifetime occupational exposure to each specific asthmagen is presented in Table 3 and 235 
Figure 1. Two thirds of the participants were exposed to at least one asthmagen over their 236 
working lifetime, and more than half of those were exposed to between one and five 237 
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occupational asthmagens. Biocides/fungicides were the most common asthmagens (49% 238 
exposed), followed by glues/resins, latex and dyes. Using an index of cumulative exposure, 239 
which accounted for both, exposure duration and estimated intensity, the highest exposures 240 
were found for wood dust and latex (Table 3). 241 
 242 
 243 
Figure 1. Lifetime prevalence of exposure to the total number of occupational asthmagens in 244 
the WHEASE cohort, n analysed=237   245 
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Table 3. Lifetime occupational exposures to asthmagens by duration of exposure and 246 
cumulative exposure index calculated within those exposed in the WHEASE cohort, n 247 
analysed = 237 248 
Occupational exposures to 
Exposed,  
n (%) 
Duration of exposure, 
years, median (IQR) 
Cumulative exposure 
indexa,  
median (IQRb) 
Any asthmagen 160 (67.5) - - 
Biocides/fungicides 115 (48.5) 20.0 (8-36) 29.0  (11.0-45.0) 
Glues/resins 92 (38.8) 20.5 (7-41) 29.5 (12.0-46.0) 
Latex 83 (35.0) 19.0 (5-35) 36.0  (8.5-149.5) 
Dyes 75 (31.6) 15.0 (6-33) 21.0 (9.0-42.0) 
Solder/flux 56 (23.6) 20.0 (10-38) 33.0 (13.0-72.0) 
Food-related asthmagens  53 (22.4) 10.0 (5-30) 30.0 (9.25-59.50) 
Wood dust 48 (20.3) 17.0 (6-37) 44.0 (20.75-121.50) 
Animal dust 43 (18.1) 12.0 (5-27) 21.5 (9.75-66.0) 
Enzyme products 28 (11.8) 10.0 (4-22) 14.0 (4.5-26.5) 
Flour/grains dust 26 (11.0) 6.0 (3-14) 17.0 (6.0-50.0) 
Isocyanates 22 (9.3) 18.5 (6-41) 24.5 (11.25-42.0) 
aCumulative exposure measurement that combines logarithmic intensity of occupational 249 
exposure as estimated by JEM and duration of exposure. bInterquartile range 250 
 251 
3.2.Outcomes in 2014 and occupational exposure to asthmagens 252 
In univariate analyses, no difference in the prevalence of respiratory outcomes was found 253 
with exposure to any of  dyes (n exposed=75), enzyme products (n=28), flour/grain dust 254 
(n=26), and isocyanates (n=22). With other asthmagens, the prevalence of all outcomes was 255 
higher in the exposed compared to non-exposed (Supplemental Material, Table S2). 256 
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Consistent upward trends in the prevalence of AOW, diagnosed COPD, FEV1<LLN and 257 
FEV1/FVC<0.7 were observed among those exposed to food-related asthmagens and to 258 
biocides/fungicides, and in the prevalence of AOW and FEV1/FVC<0.7 among those exposed 259 
to wood dust.  260 
 261 
Compared to non-exposed those exposed to food-related asthmagens had reduced FEV1, FVC 262 
and FEF25-75% (p<0.01).  A similar trend for FEV1, and FEF25-75% (p<0.05) was observed with 263 
exposure to biocides/fungicides (Supplemental Material, Table S3). AOW, COPD, and 264 
reduced FEV1 were also more common with exposure to a greater number of asthmagens in 265 
the workplace (Supplemental Material, Table S4).  266 
 267 
Table 4 presents the results of adjusted logistic and linear regression models of the 268 
relationship between the outcomes and the number of occupational pollutants and exposure 269 
ever to specific asthmagens. Exposure to a greater number of asthmagens was associated with 270 
a higher likelihood of having AOW, with occupational exposure to more than four 271 
asthmagens being associated with three times increased risk of AOW (Table 4). No 272 
association was found between total number of asthmagens and spirometric outcomes. 273 
Occupational exposure to glues, latex, solder was also associated with increased risk of 274 
AOW, but not spirometric indices. Occupational exposure to food-related asthmagens was 275 
associated with increased likelihood of AOW, FEV1<LLN, and reduced FEV1, FVC and 276 
FEF25-75%, whereas exposure to wood dust was associated with increased likelihood of AOW, 277 
FEV1/FVC<0.7, and reduced FEF25-75%, and exposure to biocides/fungicides was associated 278 
with increased likelihood of AOW and FEV1<LLN (Table 4). Inclusion of appropriate 279 
interaction terms demonstrated no significant interaction between cigarette smoking and the 280 
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associations with exposure to food-related asthmagens, wood dust or biocides/fungicides. 281 
Due to the small number of cases, COPD could not be analysed in such multi-variate models. 282 
 283 
Separate models were run to examine exposures to specific asthmagens in the longest and 284 
current/last held jobs. While the prevalence of exposure was markedly lower in these models 285 
(Tables S5-S6, Supplemental Material), compared to the models examining lifetime 286 
exposure, the results in general were consistent. AOW, FEV1<LLN, and reduction in FEF25-287 
75% were related to exposure to biocides/fungicides (n exposed=70, adjusted ORs 95%CI 2.56 288 
[1.41, 4.64], 3.37 [1.25, 9.09], regression coefficient 95%CI -10.96 [-20.16, -1.76], 289 
respectively) and reduction in FVC to exposure to food asthmagens (n exposed=25, adjusted 290 
regression coefficient 95%CI -7.67 [-14.03, -1.31]) in the longest held job (Supplemental 291 
Material, Table S5). Analysis of exposures in the current/last held jobs produced similar but 292 
less marked results with or without additional adjustment for age at hire (Supplemental 293 
Material, Table S6a and S6b). 294 
18 
 
 
Table 4. Adjusted logistic and linear regression analyses of the associations between respiratory outcomes and occupational asthmagen exposure 295 
in the WHEASE cohort in 2014; n analysed=237 296 
Asthmagen exposure 
Adjusteda OR 95%CI Adjusteda regression coefficient 95%CI 
AOW FEV1<LLN FEV1/FVC<0.7 FEV1 % predicted FVC % predicted FEF25-75% % predicted 
Model A 
Total number (0-11) b 
1.24 
(1.11, 1.39) 
1.17 
(0.97, 1.42) 
1.04 
(0.93, 1.16) 
-0.36 
(-1.16, 0.44) 
-0.44 
(-1.22, 0.35) 
-0.98 
(-2.64, 0.68) 
Model B 
0 
- - - - - - 
1-3 
0.63 
(0.30, 1.35) 
1.91 
(0.35, 10.36) 
1.28 
(0.62, 2.64) 
-0.96 
(-6.09, 4.17) 
-0.55 
(-5.56, 4.45) 
1.06 
(-9.67, 11.79) 
≥4 
3.24 
(1.62, 6.46) 
 4.22 
(0.83, 21.50)  
1.27 
(0.63, 2.56) 
-1.32 
(-6.31, 3.67) 
-1.44 
(-6.31, 3.43) 
-3.26 
(-13.62, 7.11) 
Model C 
Any asthmagen, n 160 
1.59 
(0.86, 2.92 
2.91 
(0.62, 13.70) 
1.28 
(0.68, 2.38) 
-1.15 
(-5.63, 3.33) 
-1.02 
(-5.39, 3.35) 
-1.26 
(-10.60, 8.09) 
Models D       
Biocides/fungicides, n 115 
1.79 
(1.04, 3.11) 
3.37 
(1.06, 10.78) 
1.47 
(0.84, 2.58) 
-3.18 
(-7.28, 0.93) 
-2.98 
(-6.99, 1.03) 
-6.43 
(-14.97, 2.11) 
Glues/resins, n 92 
2.95 
(1.62, 5.39) 
1.31 
(0.44, 3.89) 
0.92 
(0.50, 1.70) 
2.56 
(-1.88, 6.99) 
1.94 
(-2.39, 6.27) 
0.45 
(-8.79, 9.70) 
Latex, n 83 
2.93 
(1.66, 5.17) 
2.42 
(0.92, 6.38) 
1.31 
(0.74, 2.31) 
-2.06 
(-6.28, 2.15) 
-1.28 
(-5.41, 2.84) 
-5.19 
(-13.94, 3.56) 
Solder/flux, n 56 
2.28 
(1.17, 4.42) 
1.06 
(0.31, 3.62) 
1.05 
(0.53, 2.06) 
3.87 
(-1.14, 8.88) 
3.08 
(-1.82, 7.97) 
6.21 
(-4.21, 16.63) 
Food-related, n 53 
2.66 
(1.39, 5.09) 
2.87 
(1.07, 7.66) 
1.52 
(0.79, 2.91) 
-7.20 
(-12.03, -2.36) 
-6.19 
(-10.93, -1.44) 
-13.34 
(-23.41, -3.27) 
Wood dust, n 48 
2.08 
(1.03, 4.21) 
2.66 
(0.84, 8.41)  
2.46 
(1.19, 5.09) 
-3.21 
(-8.56, 2.14) 
0.21 
(-5.03, 5.44) 
-13.76 
(-24.75, -2.77) 
Animal dust, n 43 
2.02 
(1.02, 4.01) 
1.64 
(0.52, 5.19) 
1.29 
(0.64, 2.61) 
-3.21 
(-8.44, 2.03) 
-3.46 
(-8.56, 1.65) 
-8.45 
(-19.29, 2.39) 
Model A explores the total count of exposures with outcome, model B explores a categorised count of exposures (0, 1-3, ≥4), model C explores 297 
the binary ‘any asthmagen’ exposure, models D explore each exposure on its own with outcome. 298 
19 
 
 
aAdjusted for: sex, smoking ever and highest educational qualification obtained.  299 
bContinuous data analysis. Presented ORs/regression coefficients and 95%CIs are per each additional asthmagen300 
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Similar associations were demonstrated in adjusted logistic and linear regression models that 301 
used cumulative exposure categories instead of exposure ever (Table 5). A significant trend 302 
across a range of exposures was seen between exposure to biocides/fungicides and 303 
development of AOW, FEV1<LLN and reduced FEF25-75%, and between food-related 304 
asthmagens and AOW, FEV1<LLN, reduced FEV1, FVC, and FEF25-75%.   305 
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Table 5. Adjusted logistic and linear regression analyses of the associations between respiratory outcomes and cumulative exposure to selected 306 
asthmagens in WHEASE cohort in 2014; n analysed=237 307 
Exposure 
to 
Categ
ories 
N 
Adjusteda OR 95%CI Adjusteda regression coefficient 95%CI 
AOW FEV1<LLN FEV1/FVC<0.7 FEV1  % predicted FVC % predicted FEF25-75% % predicted 
Biocides/ 
fungicides 
None 122 - 
p 
trend 
0.006 
- 
p trend 
0.024 
- 
p 
trend 
0.076 
- 
p 
trend 
0.054 
- 
p 
trend 
0.192 
- 
p 
trend 
0.044 
Low 35 
1.11 
(0.49, 2.50) 
2.46 
(0.56, 10.84) 
0.98 
(0.43, 2.24) 
-0.003 
(-5.87, 5.86) 
-2.92 
(-8.67, 2.84) 
4.17 
(-7.98, 16.32) 
Med 40 
1.68 
(0.79, 3.57) 
3.33 
(0.84, 13.22) 
1.70 
(0.79, 3.65) 
-7.54 
(-13.09, -2.00) 
-5.74 
(-11.18, -0.29) 
-12.77 
(-24.27, -1.27) 
High 40 
2.82 
(1.33, 5.99) 
4.51 
(1.14, 17.87) 
1.80 
(0.84, 3.86) 
-1.6 
(-7.10, 3.88) 
-0.40 
(-5.79, 4.99) 
-9.07 
(-20.46, 2.32) 
Food-
related 
asthmagens 
None 184 - 
p 
trend 
0.002 
- 
p trend 
0.012 
- 
p 
trend 
0.365 
- 
p 
trend 
0.003 
- 
p 
trend 
0.026 
- 
p 
trend 
0.010 
Low 17 
1.99 
(0.70, 5.68) 
0.66 
(0.08, 5.76) 
1.60 
(0.56, 4.56) 
-0.14 
(-7.86, 7.57) 
-1.63 
(-9.24, 5.98) 
-0.35 
(-16.44, 15.73) 
Med 21 
2.09 
(0.82, 5.32) 
5.34 
(1.53, 18.72) 
1.93 
(0.74, 5.02) 
-10.09 
(-16.96, -3.22) 
-7.07 
(-13.84, -0.30) 
-21.39 
(-35.72, -7.07) 
High 15 
5.49 
(1.61, 18.68) 
3.36 
(0.74, 15.20) 
1.01 
(0.32, 3.17) 
-10.74 
(-18.83, -2.66) 
-9.88 
(-17.84, -1.91) 
-16.04 
(-32.89, 0.82) 
Wood dust 
None 189 - 
p 
trend 
0.068 
- 
p  
trend 
0.068 
- 
p 
trend 
0.050 
- 
p 
trend 
0.304 
- 
p 
trend 
0.823 
- 
p 
trend 
0.044 
Low 17 
2.00 
(0.70, 5.66) 
1.05 
(0.11, 9.63) 
2.86 
(0.97, 8.44) 
-4.15 
(-11.97, 3.66) 
0.87 
(-6.80, 8.54) 
-19.28 
(-35.33, -3.22) 
Med 16 
2.21 
(0.75, 6.54) 
4.61 
(0.93, 22.81) 
2.46 
(0.81, 7.50) 
-6.43 
(-14.50, 1.64) 
-2.55 
(-10.47, 5.37) 
-15.86 
(-32.44, 0.72) 
High 15 
2.04 
(0.66, 6.32) 
2.88 
(0.61, 13.69) 
2.05 
(0.64, 6.55) 
1.63 
(-6.86, 10.12) 
2.53 
(-5.80, 10.87) 
-4.60 
(-22.04, 12.84) 
aAdjusted for: sex, smoking ever and highest educational qualification obtained. 308 
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3.3.Ventilatory function between 1989-2014 and occupational asthmagen exposure  309 
Among WHEASE 2014 participants, spirometry was performed on 191 subjects at three time 310 
points and on 45 subjects at two time points between 1989 and 2014, with a total number of 311 
663 spirometry records available for longitudinal analysis. The results of linear mixed effects 312 
modelling to assess changes in FEV1 between 1989 and 2014 in relation to exposure to 313 
selected asthmagens are presented in Table 6. When compared to those not exposed, 314 
participants exposed to any asthmagen, biocides/fungicides or food-related asthmagens lost 315 
an additional 6-8ml per year in FEV1. 316 
 317 
Table 6. Changes in FEV1 in WHEASE cohort between 1989 and 2014 in relation to 318 
exposure ever to selected asthmagens, linear mixed effects modelling adjusted for sex, age, 319 
smoking, educational qualifications, n cases 236*, n records analysed 663 320 
Asthmagen, n exposed 
Difference in decline in exposed vs non-exposed,  
FEV1 ml/year 
Estimate (95% CI of difference) p-value 
Any asthmagen,  n 160 -5.70 (-11.30, -0.10) 0.046 
Biocides/fungicides, n 115 -6.32 (-11.60, -1.03) 0.019 
Food-related asthmagens, n 53 -8.00 (-14.45, -1.55) 0.015 
Wood dust, n 48 -5.66 (-12.32, 0.99) 0.095 
*One subject with single spirometry record was excluded  321 
 322 
4. DISCUSSION 323 
This study showed that lifetime occupational exposure to food-related asthmagens, 324 
biocides/fungicides and wood dust was independently associated with AOW and reduced 325 
lung function.  A dose-response relationship was found for food-related asthmagens and 326 
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biocides/fungicides exposure. Accelerated rate of FEV1 decline was also seen with exposure 327 
to any asthmagen, biocides/fungicides or food-related asthmagens.   328 
 329 
Evidence from previous population-based studies suggests that adult-onset asthma/wheezing 330 
is associated with certain occupations, broadly defined occupational exposures, and specific 331 
asthmagens (Le Moual et al. 2004; Ghosh et al. 2013; Lillienberg et al. 2013; Arif et al. 332 
2003). It is important to note, however, that in contrast to the current study, which used 333 
participant-reported adult-onset wheeze (AOW), most published literature reports adult-onset 334 
asthma as an outcome. Occupational exposure to cleaning agents, containing 335 
biocides/fungicides (Scientific Committee on Emerging and Newly Identified Health Risks 336 
2009) in particular, has been linked to an increased risk of adult asthma (Siracusa et al. 2013; 337 
Wang et al. 2010; Ghosh et al. 2013; Lillienberg et al. 2013). The current results are similar 338 
to previous studies linking occupational exposure to food and seafood, during harvesting and 339 
processing activities, to the development and exacerbation of asthma (Jeebhay and Cartier 340 
2010). Evidence on exposure to wood dust has been, however, inconsistent. While the current 341 
results are in agreement with a recent meta-analysis of wood dust exposure and risk of adult-342 
onset asthma (Perez-Rios et al. 2010), they are in contrast to large population-based studies 343 
that failed to find a link between adult-onset asthma and wood dust exposure in the workplace 344 
(Wang et al. 2010; Ghosh et al. 2013; Lillienberg et al. 2013).   345 
 346 
Rapid decline in lung function with ongoing exposure to causative agents has been reported 347 
in diagnosed occupational asthma (Anees et al. 2006) and COPD (Harber et al. 2007) and 348 
also in studies of working population (Shi et al. 2010), while deceleration in FEV1 reduction 349 
has been observed with removal of exposure in workers with occupational asthma (de Groene 350 
et al. 2011; Jeebhay and Cartier 2010). In the general population, however, an adverse effect 351 
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on lung function from occupational exposures has been reported less consistently and mostly 352 
in relation to major groups of airborne pollutants, e.g. dusts, gases, vapours, fumes 353 
(Humerfelt et al. 1993; de Jong et al. 2014), or total asthmagens (Wang et al. 2010). The 354 
current study demonstrates for the first time the decline in lung function resulting from 355 
occupational exposure to asthmagens in those with no childhood respiratory symptoms. The 356 
effect of asthmagen exposure on FEV1 decline was comparable to that of cigarette smoking 357 
with excess FEV1 decline of 5.2-16.1 ml/year (Xu et al. 1994). The effects were particularly 358 
evident and consistent for food-related asthmagens and were replicated in the cumulative 359 
exposure model demonstrating clear dose-response patterns. For both the longest and 360 
current/last held jobs associations were demonstrated between AOW, FEV1<LLN, reduced 361 
FEV1 and FEF25-75% and exposure to biocides/fungicides, while exposure to food associated 362 
asthmagens was related to reduced FVC only. The results, however, are likely to be affected 363 
by a small sample size. 364 
 365 
 Whilst FEV1 was associated with lifetime occupational exposure to food-related asthmagens, 366 
the ratio FEV1/FVC was not significantly associated. This could potentially reflect the fact 367 
that the majority of the WHEASE population with airflow obstruction had mild COPD as 368 
defined by GOLD (GOLD 2014), of note other groups have reported associations between 369 
occupational exposures  and severe, but not mild, COPD (Mehta et al. 2012). The analysis of 370 
severe COPD was not possible in the current study due to a small number of subjects. An 371 
alternative explanation for the disparity between the associations with FEV1 and FEV1/FVC is 372 
that exposure to food-related asthmagens is that such exposures may induce conditions with a 373 
restrictive component, this would be consistent with our finding of an association between 374 
exposure to food-related asthmagens and FVC. The only population-based study to our 375 
knowledge that also examined occupational exposure to wood dust in relation to lung 376 
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function failed to find the association with spirometric airflow obstruction (Bakke et al. 1991) 377 
found in the current study. 378 
 379 
No association was found between AOW or lung function and enzyme products, flour/grain 380 
dusts or isocyanates, recognised causes of occupational asthma (Ghosh et al. 2013; 381 
Lillienberg et al. 2013). This is probably due to the small numbers exposed to these 382 
asthmagens in the WHEASE cohort (the lowest prevalence, <12%).  A much larger study 383 
with 13284 participants (Lillienberg et al. 2013) also suffered from insufficient statistical 384 
power and had to merge subjects with similar exposures to find association with “plant 385 
antigens”, including flour. Similar to others, the current study found no interaction of 386 
occupational exposure with smoking (de Jong et al. 2014). 387 
 388 
The current study found no association between exposure to any occupational asthmagen and 389 
AOW or impaired lung function, although the trend was positive. This may reflect the fact 390 
that the study was underpowered to detect small differences.  On the other hand others have 391 
also shown a higher magnitude and strength of the association with occupational exposure to 392 
specific rather than any asthmagen (Le Moual et al. 2004).  393 
   394 
In the current study AOW and reduced FEV1 were associated with exposure to a greater 395 
number of asthmagens individuals had worked with over their lifetime. A significant dose-396 
effect relationship between the number of occupational agents (dusts, gases, vapours and 397 
fumes) to which subjects were exposed and decline in FEV1 has been reported by others 398 
(Humerfelt et al. 1993). On the other hand, a higher number of workplace asthmagens, may 399 
be an indicator of higher concentrations of exposure, as workplaces using more chemicals 400 
may have poorer control measures and workers who moved jobs more frequently may have 401 
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had poorer training/knowledge of workplace risks and thus suffered higher exposures. It is, 402 
therefore, possibly the effect of exposure to higher concentrations, which may explain the 403 
increased risk of AOW and reduced lung function from having worked with a greater number 404 
of asthmagens. A synergistic effect of multiple exposures to different asthmagens in given 405 
jobs in the WHEASE cohort, however, cannot be disregarded. 406 
 407 
 408 
Without specific allergy and inhalation tests, we can only speculate about potential 409 
pathogenic mechanisms for the current associations. Most disinfectants have an irritating 410 
effect on airways, although some may induce IgE and non-IgE immunological reactions 411 
(Siracusa et al. 2013). Food-related asthmagens exposure implies inhalation of high 412 
molecular weight (HMW) compounds which may act as complete antigens through an IgE-413 
mediated mechanism (Maestrelli et al. 2009).  Not all HMW proteins in food, however, are 414 
known allergens and reactions induced by them suggest both immune- and non-immune 415 
mechanisms (Jeebhay and Cartier 2010). In contrast, wood dusts are generally classified as 416 
low molecular weight group (LMW) compounds, which are incomplete antigens with unclear 417 
pathophysiological mechanisms, although the presence of specific IgE antibodies has been 418 
reported with exposure to some wood species (Maestrelli et al. 2009). 419 
  420 
Significant associations were found between certain specific asthmagens, and reported AOW 421 
but not with reduced lung function. To minimise the possibility of false conclusions about 422 
causal associations with multiple testing carried out in the current study, only consistent 423 
associations were considered.  424 
 425 
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Approximately 8% of the cohort had FEV1<LLN and 39% had FEV1/FVC<0.7. This may 426 
reflect a bias towards people with airflow obstruction or at risk of airflow obstruction e.g. 427 
smokers participating in the study. The fixed 0.7 criterion has, however, the potential to 428 
misdiagnose cases of airway obstruction because FEV1/FVC can vary with age, height and 429 
gender.  FEV1<LLN, although less widely used, has been shown to be more specific and it is 430 
now recommended that COPD should be defined by both FEV1/FVC and FEV1 being below 431 
the LLN using appropriate reference equations (Swanney et al. 2016).  432 
 433 
Strengths of the current study include the prospective design, length of the follow-up (50-434 
years) and objective pulmonary function testing on several occasions, used in addition to 435 
self–reported AOW. A further strength was the ability to study the impact of occupational 436 
exposure on adult airway disease in subjects without childhood wheezing illness. However, it 437 
is possible that some parents might not have recalled or forgotten to report relatively 438 
mild/transient wheeze in their children.  439 
 440 
In contrast to others (Ghosh et al. 2013) we found no difference in the prevalence of exposure 441 
to asthmagens in the workplace between those who had and had not had wheezed as children, 442 
suggesting that there was no ‘hire effect’ or initial avoidance (Dumas et al. 2013) of certain 443 
occupations/exposures that could influence the results. The finding, consistent with other 444 
studies (Ghosh et al. 2013), that those with AOW had a higher unemployment rate compared 445 
to never-wheezers, could reflect continuing selection recruitment bias. 446 
    447 
Examining the relation between exposures and outcomes in a population-based study reduced 448 
bias associated with the healthy worker effect seen in studies of working populations (Dumas 449 
et al. 2013). On the other hand, characterisation of occupational exposure in any population-450 
28 
 
based study is imprecise. In the current study it was enhanced by the assessment of 451 
occupational exposure based on detailed lifetime occupational history and the asthma-specific 452 
JEM, limiting recall bias (de Vocht et al. 2005). Using JEM to the main classes of known 453 
occupational asthmagens was based on previous experience in population-based 454 
occupational/health studies (Tagiyeva et al. 2010). Validity of JEM is, however, a matter of 455 
debate (Le Moual et al. 2000). As an inherent limitation, the use of the JEM could lead to 456 
exposure misclassification, because JEMs do not reflect heterogeneity in the exposure within 457 
and between jobs/occupations (Peters et al. 2011). In contrast to expert assessment based on 458 
self-reported occupational exposures, it is likely to be non-differential misclassification that 459 
attenuates any association towards the null (Peters et al. 2011). Linkage of self-reported job 460 
titles to a JEM may also lead to potential misclassification, which cannot be disregarded even 461 
though extra information such as job tasks and industry, was also collected and used in 462 
assigning occupational exposures. Using asthma-specific JEM to known occupational 463 
asthmagens may miss some unknown asthmagen groups. Also, while the outcomes were 464 
analysed in relation to exposure to specific asthmagens, not occupations, exposure to other 465 
pollutants present in the workplace, such as additives in the food industry, may not have been 466 
accounted for. We also could not take into account the timing of exposure and the onset of 467 
AOW, we cannot therefore exclude the possibility of workers from a local industry associated 468 
with occupational asthma systematically moving to a large local employer with no 469 
occupational asthma risk. A further limitation is that the JEM utilised will not account for 470 
changes in the workplace environment/exposures since 1964. Although responder bias was 471 
reduced by using occupational history and not self-reported exposure to specific agents it 472 
might have been difficult for some to recall short-time jobs up to 50 years earlier. Multiple 473 
exposures to different asthmagens in the WHEASE cohort presented another limitation to the 474 
evaluation of the association between outcomes and a specific asthmagen. 475 
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 476 
The main limitation of this study was the small sample size and limited number of subjects 477 
exposed to specific asthmagens. This led to wide confidence intervals that may have 478 
precluded the detection of significant associations between certain exposures and outcomes. 479 
Also, due to a small number of subjects, sensitivity or stratified analyses could not been 480 
carried out to examine the effect by sex or smoking status. A further limitation was that the 481 
cohort was not designed to prospectively investigate the association between occupational 482 
exposures and respiratory health, in addition the various phases of follow up of the cohort 483 
have focussed on research issues topical at the time with the consequence that the follow up 484 
was not systematic, which affected the representativeness of the sample. Another important 485 
limitation was that the adjustment for smoking was carried out without quantification in terms 486 
of the number of cigarettes and years smoked, which could lead to residual confounding and 487 
potentially introduce a bias in the observed effects of occupational exposures. 488 
 489 
There are a number of factors and exposures with a well-recognised adverse effect on asthma 490 
and ventilatory function impairment, such as air pollution (Forbes et al. 2009), maternal 491 
smoking (Prabhu et al. 2010) and diet in pregnancy (Allan et al 2015), birthweight (Turner et 492 
al. 2010) and other early life factors (Sly and Bush 2016), which could not been accounted for 493 
in the current study, however it seems unlikely that such factors would result in a systematic 494 
exposure to a particular occupational asthmagen. 495 
 496 
Ventilatory function was measured according to the standards existing at each follow up and 497 
the same spirometer was used in 2001 and 2014 studies. Nevertheless, different equipment 498 
was used in earlier studies and different technicians/researchers carried out the measurements 499 
at each follow-up, which all could introduce biases when assessing longitudinal lung function 500 
30 
 
changes. Notably however the biases associated with less than optimal spirometry favour 501 
underestimation of airflow obstruction. These biases were minimised by using the same 502 
procedures and calibrations (3 litre syringe every 4 hours) in each of the WHEASE studies. 503 
 504 
 505 
Aberdeen has been traditionally reliant on employment by fishing and agricultural industries, 506 
reflected by the fact that a 33% of those exposed to food-related asthmagens in this study 507 
were at some point employed in the fishing industry as fish packers, filleters, fishermen or 508 
fish and chip shop workers while 25% were employed in the meat processing industry as 509 
butchers or meat factory workers. In other UK (Ghosh et al. 2013) and international studies 510 
(Wang et al. 2010) low numbers of those exposed to fish/shellfish precluded analysis of the 511 
association. In contrast, in the West Midlands isocyanates were the main cause responsible 512 
for 21% of occupational asthma (Bakerly et al. 2008), but the least common exposure in this 513 
study (11.6% exposed among AOW). Therefore the findings of this study in relation to 514 
occupational exposures may not be widely generalisable but will be representative of 515 
occupants of similar areas in terms of the job market profile.  516 
 517 
5. CONCLUSIONS 518 
In conclusion, our study lends support to the association between occupational exposures to 519 
known asthmagens and adult-onset wheeze.  In addition we identified exposure to food-520 
related asthmagens, biocides/fungicides and wood dust, as risk factors for impaired lung 521 
function and accelerated lung function decline in those without preceding childhood 522 
wheezing illness. The demonstration of amenable to intervention, occupational risk factors 523 
for lung function impairment and accelerated decline pose the important implications for 524 
occupational interventions and policies. Due to low number of subjects in some exposure and 525 
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outcome categories results, however, should be interpreted with caution and need to be 526 
replicated in a larger prospective study of a general population. Future studies should also 527 
focus on identifying and characterising specific food allergens which are responsible for the 528 
associations found in the current study.  529 
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